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CavinThe pro-inﬂammatory cytokine tumor necrosis factor-alpha (TNFα) increases expression of CD38 (amembrane-
associated bifunctional enzyme regulating cyclic ADP ribose), and enhances agonist-induced intracellular Ca2+
([Ca2+]i) responses in human airway smooth muscle (ASM). We previously demonstrated that caveolae and
their constituent protein caveolin-1 are important for ASM [Ca2+]i regulation, which is further enhanced by
TNFα. Whether caveolae and CD38 are functionally linked in mediating TNFα effects is unknown. In this regard,
whether the related cavin proteins (cavin-1 and -3) thatmaintain structure and function of caveolae play a role is
also not known. In the present study, we hypothesized that TNFα effects on CD38 expression and function in
human ASM involve caveolae. Caveolar fractions from isolated human ASM cells expressed CD38 and its expres-
sion was upregulated by exposure to 20 ng/ml TNFα (48 h). ASM cells expressed cavin-1 and cavin-3, which
were also upregulated by TNFα. Knockdown of caveolin-1, cavin-1 or cavin-3 (using siRNA) all signiﬁcantly
reduced CD38 expression and ADP-ribosyl cyclase activity in the presence or absence of TNFα. Furthermore,
caveolin-1, cavin-1 and cavin-3 siRNAs reduced [Ca2+]i responses to histamine under control conditions, and
blunted the enhanced [Ca2+]i responses in TNFα-exposed cells. These data demonstrate that CD38 is expressed
within caveolae and its function is linked to the caveolar regulatory proteins caveolin-1, cavin-1 and -3. The link
between caveolae and CD38 is further enhanced during airway inﬂammation demonstrating the important role
of caveolae in regulation of [Ca2+]i and contractility in the airway.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Intracellular Ca2+ concentration ([Ca2+]i) plays an important role in
airway smooth muscle (ASM) contraction and relaxation. Agonist-
induced [Ca2+]i responses involve Ca2+ inﬂux and sarcoplasmic reticu-
lum (SR) Ca2+ release [1–6].
Inﬂammatory cytokines, such as tumor necrosis factor-alpha (TNFα)
and interleukins such as IL-13 have been implicated as mediators in the
pathophysiology of reactive airway diseases such as asthma [7–9] and
chronic obstructive pulmonary disease (COPD) [10,11]. For example,
we and others have shown that TNFα enhances ASM contractility by
increasing agonist-induced [Ca2+]i responses [12–18]. We and others
have shown that in ASM, SR Ca2+ release involves both inositol
trisphosphate receptor [1–3] and ryanodine receptor channels [4,19].
Several studies, including our own, have shown that the second0595 (Pabelick), HL088029 and
logy, 4-184 W Jos SMH, Mayo
el.: +1 507 255 7481; fax: +1
belick).
ights reserved.messenger cyclic-ADP-ribose (cADPR) is involved in Ca2+ release via
ryanodine receptor channels [6,20]. cADPR is synthesized and degraded
by the bifunctional ectoenzyme CD38 via ADP-ribosyl cyclase and
cADPR hydrolase activities, respectively [21]. Indeed, the CD38/cADPR
pathway has been implicated in [Ca2+]i regulation in several smooth
muscle types including ASM [6,22–28]. Other studies suggest that the
CD38/cADPR signaling pathway contributes to TNFα-induced augmen-
tation of [Ca2+]i responses in ASM [29].
In a recent study [25], we demonstrated that the extent of store-
operated Ca2+ entry (SOCE) in human ASM cells is modulated by the
level of CD38 expression, which suggest that CD38 effects do not neces-
sarily involve cADPR. Accordingly, themechanisms that regulate plasma
membrane CD38 levels become important. In this regard, we previously
reported [30] the presence of caveolae and their constituent proteins
caveolin-1 and -2 in human ASM as well as the role of these plasma
membranemechanisms in [Ca2+]i regulation. The importance of caveo-
lae lies in the facts that they express a number of [Ca2+]i and other
regulatory proteins, and that ASM caveolae and caveolin-1 expression
are increased following TNFα exposure [14]. Based on these observa-
tions, we hypothesized that CD38 is expressed within caveolae, and
modulated by caveolar proteins, providing an avenue for TNFα to
upregulate CD38 in airway inﬂammation.
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2.1. Isolation of human ASM cells
The techniques for isolation of humanASMcells have been previous-
ly described [30,31]. Brieﬂy, in accordance with previously approved
procedures and considered exempt from Human Subjects classiﬁcation
by theMayo Clinic Institutional Review Board, human 3rd to 6th gener-
ation bronchi were obtained from discarded surgical specimens and
ASM cells enzymatically dissociated as described previously [30,31].
Cells were seeded into culture ﬂasks, maintained under normal condi-
tions (21% O2, 5% CO2; 37 °C) and used for experiments under serum
starved conditions prior to passage 3 of subculture. Validation of ASM
cell phenotype was performed by western analysis and RT-PCR for
smooth muscle markers [30,31].
2.2. CD38 overexpression
As recently described [25], full length CD38was generated using RT-
PCR and primers designed from published sequence (Accession #
D84276) that include the endogenous translation start and stop codons
(Forward primer sequence: 5′-ACCCCGCCTGGAGCCCTATG-3′ Reverse
primer sequence: 5′-GCTAAAACAACCACAGCGACTGG-3′). A green ﬂuo-
rescent protein (GFP)-tagged CD38 DNA construct was constructed
using standard procedures, and ASM cells were transfected with GFP-
CD38 or Lipofectamine™ 2000 (Invitrogen) alone according to
manufacturer's protocol. Cells were incubated with the transfection
mix in DMEM/F12 media without serum for 24 h and analyzed for
CD38 expression and function as previously described [25]. For [Ca2+]i
studies, DMEM/F12 containing 10% FBS was added 4 h post-
transfection and maintained for 24 h. This medium was replaced with
serum free DMEM/F12media for an additional 48 h to drive cells to qui-
escence prior to [Ca2+]i measurements.
2.3. Preparation of caveolar membranes
We have previously described techniques for preparation of
caveolin-rich membranes from human ASM cells [30]. Brieﬂy, ASM
cells were homogenized in cold buffer A (0.25 M sucrose, 1 mM EDTA,
and 20 mM Tricine, pH 7.8), layered onto a 30% Percoll gradient, and
centrifuged at 84,000 ×g for 30 min. The crude membrane fraction
was then sonicated, resuspended and normalized to equal protein
concentration and a linear 20% to 10% OptiPrep gradient was layered
on top for re-centrifugation. The upper membrane layer (containing
caveolae) was collected for further experimentation. Equal volumes of
caveolae enriched fraction were loaded for western blot analysis to
account for comparable measurements of caveolar proteins within
caveolae.
2.4. Caveolin-1, cavin-1, and cavin-3 knockdown
The technique for knocking down of caveolar proteins in human
ASM using siRNA has also previously been described [30,32]. siRNA
duplex oligonucleotides were purchased from Dharmacon (Lafayette,
CO). ASM cells at 60% conﬂuence were transfected using 50 nM siRNA
and Lipofectamine in DMEM F/12 without FBS. Fresh growth medium
was added 6 h following transfection and cells processed after 48 h.
Efﬁcacy of siRNA knockdown was veriﬁed by western analysis.
2.5. Measurement of ADP-ribosyl cyclase activity
The ﬂuorescence-based assay of the conversion of the NAD analog,
NGD, to the non-hydrolyzable ﬂuorescent product cGDPR as an index
of ADP-ribosyl cyclase activity has been previously described [33]. Brief-
ly, normal medium was replaced with HBSS containing 400 μM NGD
with or without TNFα. HBSS with NGD in cells without cells served asbackground. After 24 h (during which cells were maintained under
standard culture conditions), an aliquot of medium was removed
and ﬂuorescence measured (excitation 305 nm, emission 410 nm;
Amersham spectroﬂuorometer). Changes in ﬂuorescence above back-
ground were considered as valid conversions from NGD to cGDPR.2.6. Western blot analysis
Standard techniques were used to separate proteins of interest by
SDS-PAGE, transfer to PVDFmembranes, blockingwith 5%milk, incuba-
tion overnight with 1 μg/ml primary antibodies and detection of bands
with either horseradish peroxidase-conjugated secondary antibodies or
chemiluminescence substrate (Supersignal West Pico, Pierce Chemical
Co., Rockford, IL). Signal was developed using Supersignal West Pico
Chemiluminescent substrate or far-red ﬂuorescent dye-conjugated
antibodies. Blots were imaged on a Kodak Image Station 4000MM
(Carestream Health, New Haven, CT) or a LiCor OdysseyXL system,
and quantiﬁed using densitometry.2.7. Fluorescence [Ca2+]i imaging
These techniques have been extensively described [25,34,35]. Cells
were incubated for 45 min in 5 μM fura-2/AM. ASM cells were initially
perfused with 2.5 mM Ca2+ HBSS and baseline ﬂuorescence levels
were established. The [Ca2+]i responses of 15–30 cells per chamber
were achieved using software-deﬁned regions. The ratiometric mea-
surements of 510 nm emissions following 340/380 nm excitations
were recorded every 750 ms using a videoﬂuorescence imaging system
(Molecular Devices, Sunnyvale, CA). In regard to the histamine-induced
[Ca2+]i responses, the amplitudes of [Ca2+]i responses were calculated
by subtracting the baseline [Ca2+]i level from the peak [Ca2+]i
responses.[22,25].2.8. Materials
Antibodies to caveolin-1 (Abcam, #ab18199), CD38 (Epitomics,
#2935-1), cavin-1 (Novus Biologicals, #NB100-60635), cavin-3 (Abcam,
#ab76676), andGAPDH (Cell Signaling, #2118)were purchased as listed.
DMEM, antibiotic/antimycotic mixture as well as Fura-2 were obtained
from Invitrogen, Grand Island, NY. Unless mentioned otherwise all
chemicals were purchased from Sigma-Aldrich, St. Louis, MO.2.9. Statistical analysis
Experimentswere performedusing ASMcells derived from at least 5
different patients, although not all protocols were performed in each
sample. Each protocol was repeated at least 5 times. Statistical analysis
was performed using unpaired Student's t test or 2-way ANOVA with
repeated measures when necessary (Bonferroni correction for repeated
measures). Data are shown asmean ± SEM. Statistical signiﬁcance was
set at p b 0.05.3. Results
3.1. Caveolar protein expression and upregulation with TNFα
We previously demonstrated caveolin-1 expression and its upregu-
lation within caveolar fractions following TNFα exposure [14]. In the
present study, we found that CD38 as well as the caveolar structural
regulatory proteins cavin-1 and cavin-3 are expressed within caveolar
fractions of human ASM cells (Fig. 1). All these proteins are signiﬁcantly
upregulated in the presence of TNFα (Fig. 1; p b 0.05).
Fig. 1. Caveolar expression of CD38. In caveolar fractions of humanASM cells, considerable
CD38 expression was observed at baseline. Caveolar fractions expressed the constitutive
protein caveolin-1 as well as the structural regulatory proteins cavin-1 and cavin-3 that
determine caveolin-1 insertion into plasma membrane (and thus invagination) and cave-
olin internalization, respectively. Overnight exposure to TNFα signiﬁcantly increased
expression of all these proteins (CD38, caveolin-1, cavin-1, and cavin-3). * in bar graph
indicates signiﬁcant TNFα effect (p b 0.05).
Fig. 2. Effect of caveolar protein knockdown on CD38 expression in human ASM cells.
siRNA knockdown of caveolin-1, cavin-1, or cavin-3 all signiﬁcantly reduced caveolar
CD38 expression in human ASM at baseline. TNFα-induced increase in CD38 expression
was substantially blunted by siRNA against caveolin-1, cavin-1, and particularly cavin-3
(A). The siRNA efﬁcacy of all three caveolar proteins was veriﬁed using western blot anal-
ysis (B). Values aremean ± SEM. * indicates signiﬁcant siRNA effect, # indicates signiﬁcant
effect of TNFα (p b 0.05).
Fig. 3. Effect of caveolar protein knockdown on ADP-ribosyl cyclase activity. siRNA knock-
down of caveolin-1, cavin-1 or cavin-3 signiﬁcantly reduced ADP-ribosyl cyclase activity.
TNFα enhancement of cyclase activity was reduced to an even greater extent by siRNAs
against all three proteins. Values are mean ± SEM. * indicates signiﬁcant siRNA effect,
# indicates signiﬁcant effect of TNFα (p b 0.05).
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siRNA suppression of caveolin-1, cavin-1, or cavin-3 expression all
signiﬁcantly reduced CD38 expression in human ASM (Fig. 2A,
p b 0.05). Surprisingly, cavin-3 siRNA was most effective in reducing
CD38 expression. The signiﬁcant increase in CD38 expression following
TNFα exposurewas still blunted by knockdown of caveolin-1, cavin-1 or
cavin-3 (Fig. 2A, p b 0.05), and to a greater extent compared to non-
TNFα exposed cells. Here too, cavin-3 siRNA was most effective. Trans-
fection with small interference RNA (siRNA) speciﬁc for caveolin-1,
cavin-1 or cavin-3 resulted in signiﬁcant reduction in speciﬁc protein
expression. Vehicle (Lipofectamine) or negative siRNA had no signiﬁ-
cant effect on protein expression (Fig. 2B, p b 0.05).
3.3. Effect of caveolar protein knockdown on ADP-ribosyl cyclase activity
Compared to baseline, exposure to TNFα signiﬁcantly enhanced
ADP-ribosyl cyclase activity (Fig. 3, p b 0.05) consistent with increased
CD38 expression. siRNA-induced suppression of caveolin-1, cavin-1,
and cavin-3 all signiﬁcantly reduced ADP-ribosyl cyclase activity in
ASM cells with or without TNFα exposure (Fig. 3, p b 0.05), with
proportionately greater effects in TNFα-exposed cells.
3.4. Effect of caveolin-1, cavin-1 and cavin-3 siRNAs on [Ca2+]i response to
agonist
In fura-2 loaded control (i.e. non-transfected, non-TNFα exposed,
Lipofectamine only) ASM cells, baseline [Ca2+]i was ~100–180 nM
(mean 154 ± 14 nM). Exposure to 10 μM histamine produced charac-
teristic biphasic [Ca2+]i responses, which we have also reported previ-
ously [14]. Consistent with previous results [14,15], exposure to TNFα
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control (Fig. 4C,D; p b 0.05). In cells exposed to caveolin-1, cavin-1 or
cavin-3 siRNA, [Ca2+]i responses to histamine were signiﬁcantly
reduced in comparison to vehicle (Fig. 4 A,B, p b 0.05). In cells exposed
to TNFα, caveolin-1, cavin-1, and cavin-3 siRNAs blunted the enhance-
ment of [Ca2+]i responses due to this cytokine (Fig. 4C,D; p b 0.05).
3.5. CD38 overexpression and [Ca2+]i responses
Overexpression of CD38 increased [Ca2+]i responses to histamine
compared to vehicle (Lipofectamine only; Fig. 5, p b 0.05). This enhanc-
ing effectwas as pronounced aswith exposure to TNFα. The combination
of CD38 overexpression and TNFα exposure even further enhanced
[Ca2+]i responses (Fig. 5, p b 0.05). To investigatewhether the increased
[Ca2+]i responses in the presence of CD38 overexpression and/or TNFα
are linked to changes in caveolar proteins, we used caveolin-1, cavin-1
or cavin-3 siRNA under these experimental conditions. Downregulation
of caveolin-1, cavin-1 or cavin-3 using siRNA signiﬁcantly reduced
[Ca2+]i responses under all these experimental conditions (control,
TNFα, CD38 overexpression, and CD38 overexpression plus TNFα;
Fig. 5, p b 0.05).
4. Discussion
In this study, we present novel data demonstrating that caveolar
CD38 expression is linked to TNFα-induced augmentation of [Ca2+]i
responses to agonist stimulation in ASM. In this regard, we found that
CD38 expression within caveolae is regulated by the cavin proteins
that happen to be important for caveolar structure (cavin-1) and traf-
ﬁcking (cavin-3). Exposure to TNFα upregulates such mechanisms,
resulting in enhanced caveolar CD38 which in turn leads to increased
ADP ribosyl cyclase activity and [Ca2+]i. However, such enhancement
of CD38 is not unidirectional in the sense that caveolae in turn can
regulate CD38 function as well. This is demonstrated by the ﬁndings
that inhibition of caveolin-1, cavin-1 and cavin-3 expression leads to
blunting of CD38 effects on [Ca2+]i responses in the presence or absence
of cytokine. The relevance of these ﬁndings lies in the recognition that
both CD38 [6,22–28] and caveolae [14,32,36] are important regula-
tors of ASM [Ca2+]i and contractility, and increased expression ofFig. 4. Effect of caveolin-1, cavin-1 and cavin-3 siRNAs on intracellular Ca2+ ([Ca2+]i) response
Lipofectaminevehicle only), caveolin-1, cavin-1 and cavin-3 siRNA treated cells showed signiﬁca
[Ca2+]i responses to histamine. In the presence of TNFα, all caveolin-1 siRNA, cavin-1 siRNA an
mine (C and D). Values are mean ± SEM. * indicates signiﬁcant siRNA effect, # indicates signiﬁeither mechanism contributes to increased airway contractility
[14,25,29,32,36]. Accordingly, structural and functional linkage be-
tween the two highlights a potentially synergistic pathway by which
cytokines or other inﬂammatory factors can enhance airway contractil-
ity in the setting of airway diseases.
4.1. CD38 in ASM
We and others have demonstrated that CD38 exists in ASM, and is
involved in regulation of [Ca2+]i and contractility [25,29,37–39].
Furthermore, the link between CD38 and cADPR, synthesized by ADP-
ribosyl cyclase and degraded by cADPR hydrolase, has also been well-
established in vitro [37,40,41] as well as in vivo using CD38 knockout
mice [26,42,43]. Intracellular cADPR levels can be modulated via CD38
expression and function, for example by neurotransmitters and cyto-
kines (IL-1, TNFα) [29,44,45]. In human ASM cells, we previously
reported that TNFα increases CD38 expression as well as activity as
determined using an NGD assay: effects inhibited by CD38 siRNA [25].
Furthermore, we have demonstrated that the enzymatic machinery
for cADPR metabolism exists in ASM [46], and is important for [Ca2+]i
regulation by showing that exogenous cADPR modulates SR Ca2+
release via ryanodine channels [6]. In human ASM, cADPR produc-
tion occurs with several bronchoconstricting agents (acetylcholine,
endothelin-1 and histamine) [20,22]. And ﬁnally, beyond cADPR,
CD38 also has the potential to modulate [Ca2+]i via effects on Ca2+
inﬂux mechanisms such as TRPC3 [25]. Overall, these data link CD38
and [Ca2+]i regulation in ASM. Furthermore, they demonstrate that
these relationships can play a role in cytokine enhancement of [Ca2+]i
in ASM. The current study now demonstrates that such links involve
caveolar CD38 with an additional role for caveolin-1 in regulating
CD38 effects.
4.2. TNFα, CD38 and ASM
The important role of TNFα in airway inﬂammation and hyperreac-
tivity has been well-recognized [8,47,48]. Here, several targets and
mechanisms for TNFα effects, including [Ca2+]i regulatory pathways,
have been identiﬁed in ASM [13,49]. Relevant to this study, we and
others [14,50] have shown that TNFα enhances caveolin-1 expressions to agonist in human ASM cells. Compared to control cells (non-transfected, treated with
ntly reduced [Ca2+]i responses to 10 μMhistamine (Aand B). TNFα signiﬁcantly enhanced
d cavin-3 siRNA treated cells still showed signiﬁcantly smaller [Ca2+]i responses to hista-
cant effect of TNFα (p b 0.05).
Fig. 5. Role of caveolin-1, cavin-1 and cavin-3 in the regulation of CD38 effects. Overex-
pression of CD38 using a GFP-tagged construct resulted in a signiﬁcant increase in
[Ca2+]i responses to 10 μM histamine. This effect is as pronounced as the TNFα-induced
increase in [Ca2+]i responses. Combination of TNFα and GFP-CD38 even further enhanced
the increase in [Ca2+]i responses. Under these different conditions, caveolin-1, cavin-1 or
cavin-3 siRNA treated cells showed signiﬁcantly reduced [Ca2+]i responses under all
conditions (vehicle; CD38 overexpression, TNFα, CD38 overexpression plus TNFα)
suggesting that caveolar proteins modulate CD38 effects. Values are mean ± SEM. # indi-
cates signiﬁcant siRNA effect, * indicates signiﬁcant effect of TNFα (compared to
control), % indicates signiﬁcant CD38 effect (p b 0.05).
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have already shown that TNFα increases CD38 expression [25,29,35].
Furthermore, the CD38/cADPR signaling pathway is involved in TNFα-
induced increase in airway responsiveness [29]. For example, adenovi-
ral mediated anti-sense CD38 transfection leads to blunted [Ca2+]i
responses to agonist [51], while CD38 overexpression leads to enhanced
[Ca2+]i responses as well as store-operated Ca2+ inﬂux [25]. The
present study shows that TNFα induced alterations in CD38 are linked
to changes in caveolar proteins which in turn can regulate CD38
function.
4.3. Caveolae in ASM
Caveolae are ﬂask-shaped invaginations of the plasma membrane
that are enriched in cholesterol, sphingolipids, and integral membrane
proteins called caveolins. Caveolin-enriched domains harbor a range
of proteins and facilitate binding of intracellular as well as extracellular
moieties, and therefore can have profound effects on signaling between
plasma membrane regulatory components and intracellular structures.
There is currently no information on caveolar localization of CD38 in
any tissue. In this regard, the results of the current study are novel. By
co-expressing CD38 alongwith agonist receptors andmultiple regulato-
ry proteins such as agonist receptors and inﬂux channels, caveolae may
facilitate interactions between these proteins and thus enhance [Ca2+]i
and other signaling. Accordingly, mechanisms that regulate caveolar
structure and the protein composition of caveolae become important
in the context of regulatory proteins such as CD38.
The results of the present study show that in human ASM, caveolar
CD38 expression is regulated by caveolin-1 as well as two cavins that
themselves modulate caveolar structure and function. ASM from differ-
ent species has now been shown to express caveolin-1 (and to a lesser
extent caveolin-2) [30,52–54]. We and others have also shown that
caveolin-1 expression and its effects on [Ca2+]i per se are enhanced in
the presence of cytokines such as TNFα. Such effects are mediated, at
least in part, by caveolin-1 itself, as well as signaling intermediates such
as MAPK and NFκB. Thus caveolin-1 is an integral aspect of caveolar ef-
fects in ASM. What is novel in this study is the demonstration that
caveolin-1 regulates the expression and functionof an important enzyme
such as CD38 that is not simply due to altered caveolar levels per se.
In addition to caveolin-1, two relatively novel regulatory proteins,
cavin-1 (or PTRF) and cavin-3 (or SRBC) also appear to be important
for CD38 expression and its activity. There is currently very littleinformation on cavin expression patterns in ASM, or their role in ASM
caveolar expression/function or other pathways. Here, the results of
the present study showing robust cavin-1 and cavin-3 expression in
human ASM are also novel, as are the data that TNFα substantially
increases expression of both proteins. A primary role of these proteins
is control of caveolin-1 levels within caveolae (by enhancing plasma
membrane insertion vs. internalization). Accordingly, the overall level
of caveolin-1 (a relatively stable protein when in the plasma mem-
brane) is likely driven by a balance between these regulators. Here,
the increase in cavin-3 with TNFα is surprising since that should lead
to reduced plasma membrane caveolin-1, and not an increase as has
been previously reported [55]. While the focus of the present study
was not on the role of cavins in caveolin control per se, it is possible to
hypothesize that the relative contribution of cavin-1 (insertion) vs.
cavin-3 (internalization) is different. However, what is more interesting
is that cavin-3 in particular appears to regulate caveolar CD38 levels.
Given cavin-3's role, this cannot be a result of increased caveolin-1 (or
caveolae) butmust reﬂect an entirely differentmechanism that remains
to be explored. Nonetheless, the effects of cavins on CD38 expression
(and consequent function) demonstrate the importance of caveolar
proteins in regulation of CD38, particularly in the presence of cytokines.
In conclusion, the present study demonstrates that TNFα induced
augmentation of [Ca2+]i responses to agonist in human ASM is mediat-
ed via changes in caveolar CD38, driven by effects of caveolin-1 as well
as the regulatory proteins cavin-1 and cavin-3. Such changes may
further lead to increased cADPR levels, and thus increased [Ca2+]i
responses due to release via ryanodine channels, which can contribute
to the enhanced airway contractility that occurs with inﬂammation.
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